In patients with acute coronary syndrome (ACS), Il6 serves as a critical biomarker for assessing both the severity of coronary artery disease (CAD) and the risk of mortality (Su et al., 2013; Mowafy et al., 2015; Fanola et al., 2017). The gene discussed is IL6; the disease is acute coronary syndrome.